Impact of behavioral side effects on the management of Parkinson patients treated with dopamine agonists

Dopamine agonists are one of the main stay of treatment option for Parkinson disease (PD). Side effects that develop from their use are generally categorized into behavioral and non-behavioral. Behavioral side effects include: impulse control behavior disorder (ICD), psychosis and cognitive impairme...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammad, Mohammad Edrees, Vizcarra, Joaquin A., Garcia, Xiomara, Patel, Shnehal, Margolius, Adam, Yu, Xin Xin, Fernandez, Hubert H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299972/
https://www.ncbi.nlm.nih.gov/pubmed/34316669
http://dx.doi.org/10.1016/j.prdoa.2021.100091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299972/
https://www.ncbi.nlm.nih.gov/pubmed/34316669
http://dx.doi.org/10.1016/j.prdoa.2021.100091

Ejemplares similares